CN108485879A - 一种量子酒 - Google Patents
一种量子酒 Download PDFInfo
- Publication number
- CN108485879A CN108485879A CN201810192101.1A CN201810192101A CN108485879A CN 108485879 A CN108485879 A CN 108485879A CN 201810192101 A CN201810192101 A CN 201810192101A CN 108485879 A CN108485879 A CN 108485879A
- Authority
- CN
- China
- Prior art keywords
- wine
- quantum
- present
- threonine
- leucine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000014101 wine Nutrition 0.000 title claims abstract description 23
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000004475 Arginine Substances 0.000 claims abstract description 8
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000004471 Glycine Substances 0.000 claims abstract description 8
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims abstract description 8
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims abstract description 8
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims abstract description 8
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000004472 Lysine Substances 0.000 claims abstract description 8
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims abstract description 8
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000004473 Threonine Substances 0.000 claims abstract description 8
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims abstract description 8
- 235000003704 aspartic acid Nutrition 0.000 claims abstract description 8
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 235000013922 glutamic acid Nutrition 0.000 claims abstract description 8
- 239000004220 glutamic acid Substances 0.000 claims abstract description 8
- 210000000582 semen Anatomy 0.000 claims abstract description 8
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims abstract description 7
- 235000004279 alanine Nutrition 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 229920001184 polypeptide Polymers 0.000 claims description 7
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 7
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 7
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 4
- 239000008280 blood Substances 0.000 abstract description 3
- 210000004369 blood Anatomy 0.000 abstract description 3
- 230000035622 drinking Effects 0.000 abstract description 3
- 230000036541 health Effects 0.000 abstract description 3
- 230000004089 microcirculation Effects 0.000 abstract description 3
- 150000002989 phenols Chemical class 0.000 abstract description 3
- 230000003860 sleep quality Effects 0.000 abstract description 3
- 238000011282 treatment Methods 0.000 abstract description 3
- 230000000638 stimulation Effects 0.000 abstract description 2
- 230000002792 vascular Effects 0.000 abstract description 2
- 235000020097 white wine Nutrition 0.000 description 4
- 239000000203 mixture Substances 0.000 description 3
- 235000013334 alcoholic beverage Nutrition 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000020068 maotai Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
- C12G3/00—Preparation of other alcoholic beverages
- C12G3/04—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
- A61K38/446—Superoxide dismutase (1.15)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y115/00—Oxidoreductases acting on superoxide as acceptor (1.15)
- C12Y115/01—Oxidoreductases acting on superoxide as acceptor (1.15) with NAD or NADP as acceptor (1.15.1)
- C12Y115/01001—Superoxide dismutase (1.15.1.1)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Anesthesiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
Abstract
本发明公开了一种量子酒，包括下述原料：黄精液0.7～1mg/100ml、天冬氨酸0.7～1mg/100ml、苏氨酸0.1～0.2mg/100ml、丝氨酸0.2～0.5mg/100ml、谷氨酸0.3～0.5mg/100ml、赖氨酸0.2～0.5mg/100ml、亮氨酸0.1～0.3mg/100ml、精氨酸0.2～0.4mg/100ml、丙氨酸0.1～0.3mg/100ml、甘氨酸0.1～0.3mg/100ml。本发明的量子酒有特定比例的酚类化合物，不仅对饮用者的身体降低刺激，更具有修复血管壁、清除血液垃圾、改善人体微循环、提高睡眠质量等酒疗作用，满足人们健康饮酒的需求。
Description
技术领域
本发明属于酒领域，具体地说，涉及一种量子酒。
背景技术
随着人类文明的飞速发展，白酒的社会属性也被人们不断的放大。社交场合、朋友聚会等重大活动，即有餐的情况下都离不开酒的影子。经济水平越高，白酒的影响力越大，市场需求直接关系着白酒的产能和质量，当产能不足时，生产者就会想方设法提高出酒率，各种勾兑、掺合等层出不穷。产量出来了，口味也有了，但真正白酒的疗效却弱了，甚至产生相反的作用，以至人们喝酒越喝越出问题。
量子酒是采用世界前沿科技量子技术经过特殊加工工艺，将传统白酒中的有害物质最大限度地排除，同时使酒里含有丰富的对人体健康有益的酚类化合物，并将酒精度恰好保持在最科学的浓度(53％)上，量子的震动让酒分子之间的连接断裂，震动使酒分子更加均匀，对人体有用的分子体变小，更有利于身体的吸收。
有鉴于此特提出本发明。
发明内容
本发明要解决的技术问题在于克服现有技术的不足，提供一种量子酒，口感好，大大降低对身体的刺激，具有扩张血管、降低血脂血糖、改善人体微循环、提高睡眠质量等酒疗作用。
为解决上述技术问题，本发明采用技术方案的基本构思是：
一种量子酒，包括下述原料：黄精液0.7～1mg/100ml、天冬氨酸0.7～1mg/100ml、苏氨酸0.1～0.2mg/100ml、丝氨酸0.2～0.5mg/100ml、谷氨酸0.3～0.5mg/100ml、赖氨酸0.2～0.5mg/100ml、亮氨酸0.1～0.3mg/100ml、精氨酸0.2～0.4mg/100ml、丙氨酸0.1～0.3mg/100ml、甘氨酸0.1～0.3mg/100ml。
进一步地，还包括下述原料：SOD 12～16mol/100ml、多肽0.01～0.02mol/100ml。
进一步地，包括以下原料：黄精液0.86mg/100ml、天冬氨酸0.84mg/100ml、苏氨酸0.13mg/100ml、丝氨酸0.38mg/100ml、谷氨酸0.45mg/100ml、赖氨酸0.36mg/100ml、亮氨酸0.26mg/100ml、精氨酸0.34mg/100ml、丙氨酸0.22mg/100ml、甘氨酸0.20mg/100ml、SOD14.38mol/100ml、多肽0.012mol/100ml。
采用上述技术方案后，本发明与现有技术相比具有以下有益效果。
本发明的量子酒有特定比例的酚类化合物，不仅对饮用者的身体降低刺激，更具有修复血管壁、清除血液垃圾、改善人体微循环、提高睡眠质量等酒疗作用，满足人们健康饮酒的需求。
本发明以中国酒都茅台镇优质酱香型白酒为载体，精选独特典型的基酒与生物活性酶充分溶活培植，并经量子能量波高速振动紧密融合而成。
本发明配方是无色无异味的。跟茅台酱香白酒一样的颜色。这是在国内配制酒中少有的技术。国内的所有配制酒都是有色有异味的。本发明是国内首款无色无异味的首款酱香型的功能酒。
具体实施方式
为使本发明实施例的目的、技术方案和优点更加清楚，下面对实施例中的技术方案进行清楚、完整地描述，以下实施例用于说明本发明，但不用来限制本发明的范围。
实施例一
一种量子酒包括以下组分：黄精液0.7mg/100ml、天冬氨酸0.7mg/100ml、苏氨酸0.1mg/100ml、丝氨酸0.2mg/100ml、谷氨酸0.3mg/100ml、赖氨酸0.2mg/100ml、亮氨酸0.1mg/100ml、精氨酸0.2mg/100ml、丙氨酸0.1mg/100ml、甘氨酸0.1mg/100ml、SOD12mol/100ml、多肽0.01mol/100ml。
实施例二
一种量子酒包括以下组分：黄精液0.86mg/100ml、天冬氨酸0.84mg/100ml、苏氨酸0.13mg/100ml、丝氨酸0.38mg/100ml、谷氨酸0.45mg/100ml、赖氨酸0.36mg/100ml、亮氨酸0.26mg/100ml、精氨酸0.34mg/100ml、丙氨酸0.22mg/100ml、甘氨酸0.20mg/100ml、SOD14.38mol/100ml、多肽0.012mol/100ml。
实施例三
一种量子酒包括以下组分：黄精液1mg/100ml、天冬氨酸1mg/100ml、苏氨酸0.2mg/100ml、丝氨酸0.5mg/100ml、谷氨酸0.5mg/100ml、赖氨酸0.5mg/100ml、亮氨酸0.3mg/100ml、精氨酸0.4mg/100ml、丙氨酸0.3mg/100ml、甘氨酸0.3mg/100ml、SOD 16mol/100ml、多肽0.02mol/100ml。
以上所述仅是本发明的较佳实施例而已，并非对本发明作任何形式上的限制，虽然本发明已以较佳实施例揭露如上，然而并非用以限定本发明，任何熟悉本专利的技术人员在不脱离本发明技术方案范围内，当可利用上述提示的技术内容作出些许更动或修饰为等同变化的等效实施例，但凡是未脱离本发明技术方案的内容，依据本发明的技术实质对以上实施例所作的任何简单修改、等同变化与修饰，均仍属于本发明方案的范围内。
Claims (3)
1.一种量子酒，其特征在于，包括下述原料：黄精液0.7～1mg/100ml、天冬氨酸0.7～1mg/100ml、苏氨酸0.1～0.2mg/100ml、丝氨酸0.2～0.5mg/100ml、谷氨酸0.3～0.5mg/100ml、赖氨酸0.2～0.5mg/100ml、亮氨酸0.1～0.3mg/100ml、精氨酸0.2～0.4mg/100ml、丙氨酸0.1～0.3mg/100ml、甘氨酸0.1～0.3mg/100ml。
2.根据权利要求1所述的一种量子酒，其特征在于，还包括下述原料：SOD 12～16mol/100ml、多肽0.01～0.02mol/100ml。
3.根据权利要求2所述的一种量子酒，其特征在于，包括以下原料：黄精液0.86mg/100ml、天冬氨酸0.84mg/100ml、苏氨酸0.13mg/100ml、丝氨酸0.38mg/100ml、谷氨酸0.45mg/100ml、赖氨酸0.36mg/100ml、亮氨酸0.26mg/100ml、精氨酸0.34mg/100ml、丙氨酸0.22mg/100ml、甘氨酸0.20mg/100ml、SOD14.38mol/100ml、多肽0.012mol/100ml。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810192101.1A CN108485879A (zh) | 2018-03-08 | 2018-03-08 | 一种量子酒 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810192101.1A CN108485879A (zh) | 2018-03-08 | 2018-03-08 | 一种量子酒 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108485879A true CN108485879A (zh) | 2018-09-04 |
Family
ID=63338262
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810192101.1A Pending CN108485879A (zh) | 2018-03-08 | 2018-03-08 | 一种量子酒 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108485879A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109757644A (zh) * | 2019-03-11 | 2019-05-17 | 廖成蓉 | 一种辅助分解水溶解物的方法、装置及设备 |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1058042A (zh) * | 1991-06-21 | 1992-01-22 | 常德高等专科学校 | 氨基酸低度营养白酒的制备方法 |
| CN1103662A (zh) * | 1993-12-10 | 1995-06-14 | 刘国平 | 一种全价营养酒及酿制方法 |
| CN1236811A (zh) * | 1998-05-21 | 1999-12-01 | 刘世敦 | 健身酒的配制 |
| CN1327043A (zh) * | 2001-01-21 | 2001-12-19 | 王梅枝 | 一种白酒及其专用辅料和其组合产品 |
| CN101130068A (zh) * | 2007-09-04 | 2008-02-27 | 陈坤鑫 | Sod减肥酒及其生产方法 |
| CN101696383A (zh) * | 2009-10-30 | 2010-04-21 | 安徽省科学技术研究院 | 一种黄精酒制备方法 |
| CN106947678A (zh) * | 2017-04-05 | 2017-07-14 | 广州市纳能环保技术开发有限公司 | 一种改善酒质的方法及其应用 |
-
2018
- 2018-03-08 CN CN201810192101.1A patent/CN108485879A/zh active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1058042A (zh) * | 1991-06-21 | 1992-01-22 | 常德高等专科学校 | 氨基酸低度营养白酒的制备方法 |
| CN1103662A (zh) * | 1993-12-10 | 1995-06-14 | 刘国平 | 一种全价营养酒及酿制方法 |
| CN1236811A (zh) * | 1998-05-21 | 1999-12-01 | 刘世敦 | 健身酒的配制 |
| CN1327043A (zh) * | 2001-01-21 | 2001-12-19 | 王梅枝 | 一种白酒及其专用辅料和其组合产品 |
| CN101130068A (zh) * | 2007-09-04 | 2008-02-27 | 陈坤鑫 | Sod减肥酒及其生产方法 |
| CN101696383A (zh) * | 2009-10-30 | 2010-04-21 | 安徽省科学技术研究院 | 一种黄精酒制备方法 |
| CN106947678A (zh) * | 2017-04-05 | 2017-07-14 | 广州市纳能环保技术开发有限公司 | 一种改善酒质的方法及其应用 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109757644A (zh) * | 2019-03-11 | 2019-05-17 | 廖成蓉 | 一种辅助分解水溶解物的方法、装置及设备 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103907987B (zh) | 一种多菌种混合连续发酵制备山楂果醋饮料的方法 | |
| EA200701464A1 (ru) | Безалкогольный напиток, с повышенным содержаниемho | |
| JP4975484B2 (ja) | トマト果汁含有アルコール飲料及びその製造方法 | |
| CN108485879A (zh) | 一种量子酒 | |
| CN107236658A (zh) | 白酒及其勾调方法 | |
| CN106867736A (zh) | 一种山葡萄酒的澄清剂 | |
| CN105886234B (zh) | 一种纯天然的竹筒发酵酒的制作方法 | |
| CN104256460A (zh) | 一种黄瓜酱菜及其制作方法 | |
| KR20010017339A (ko) | 수액간장 및 그의 제조방법 | |
| CN108977331A (zh) | 一种玫瑰保健醋 | |
| CN107345193A (zh) | 一种柿子果酒的制作方法 | |
| KR20120054343A (ko) | 발효매실원액의 제조방법 및 이로 제조된 발효매실원액을 이용한 매실음료 조성물 | |
| US20210153537A1 (en) | Compound beverage containing corn peptides and pueraria root extract and preparation method thereof | |
| CN107629908A (zh) | 蜂蜜发酵酒 | |
| CN105907507B (zh) | 鲜味葡萄酒及其制备方法 | |
| CN105349350A (zh) | 一种竹蔗马蹄味调和鸡尾酒及其制备方法 | |
| DE58907936D1 (de) | Verfahren zur Herstellung eines Milchsäurekonzentrats. | |
| CN107988027A (zh) | 一种纯天然健康米酒 | |
| JP4530398B2 (ja) | 清酒及びその製造方法 | |
| RU1837805C (ru) | "Композици тонизирующего напитка "Напареули" | |
| RU2110564C1 (ru) | Водка особая "арму" | |
| CN208510556U (zh) | 一种具有醒酒功能的红酒杯 | |
| JPS6317678A (ja) | ワインレツドカラ−シソエキスの製造法 | |
| JP2003102451A (ja) | 黒麹もろみ酢からなる健康飲料 | |
| CN118165795A (zh) | 一种低醇葡萄汽酒配制工艺 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180904 |
|
| RJ01 | Rejection of invention patent application after publication |